Patients with cystic fibrosis attending at the cystic fibrosis units of Madrid: Cross-sectional study of 387 subjects;Pacientes con fibrosis quística atendidos en las unidades de fibrosis quística de la Comunidad de Madrid: Estudio transversal de 387 casos

Medicina Clinica

Volumn 122, Issue 18, 2004, Pages 698-700

  García Hernández, Gloria ^a   Antelo, Carmen ^b   Maiz, Luis ^c   Girón, Rosa María ^d   Salcedo, Antonio ^e   Martínez Gimeno, Antonio ^a   Martínez, María Teresa ^a   Barrio, María Isabel ^b   Prados, Concepción ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Cystic fibrosis; Diabetes mellitus; Lung function; Pancreatic insufficiency; Pseudomonas aeruginosa

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BACTERIAL COLONIZATION; BODY MASS; CHILD; CHROMOSOME ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HEALTH CARE FACILITY; HOMOZYGOSITY; HUMAN; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PREVALENCE; PSEUDOMONAS AERUGINOSA; REGISTER; SCORING SYSTEM; SPAIN;

EID: 2942538026     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062169     Document Type: Article

References (22)

1. th ed. New York: McGrave-Hill, Inc., 2001; p. 5121-88.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel G, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-73.
3. Ratjen F, Döring G. Cystic fibrosis. Lancet 2003;361:681-9.
4. Quanjer PH. Standarized lung function testing. Eur Respir J 1993;6(Suppl 6):3-102.
5. Hernández M, Castellet J, Narvaíza JL, Rincón JM, Ruiz I, Sánchez E, et al. Curvas y tablas de crecimiento. Madrid: Ediciones Ergón S.A., 2002.
6. Cystic Fibrosis Foundation. Patient Registry 2001 Annual Report. Bethesda, Maryland.
7. Chillón M, Casals T, Giménez J, Ramos MD, Palacio A, Morral N, et al. Analysis of the CFTR gene confirms the high genetic heterogeneity of the Spanish population: 43 mutations account for only 78% of CF chromosomes. Hum Genet 1994;93:447-51.
8. Nunes V, Gasparini P, Novelli G, Gaona A, Bonizzato A, Sangiuolo F, et al. Analysis of 14 cystic fibrosis mutations in five South European populations. Hum Genet 1991;87:737-8.
9. Cystic Fibrosis Genetic Analysis Consortium. Populations variation of common cystic fibrosis mutations. Hum Mutat 1994;4:167-77.
10. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003;361:1671-6.
11. De Gracia J, Álvarez A, Mata F, Guarner M, Vendrell M, Gadtner S, et al. Fibrosis quística del adulto: estudio de 111 pacientes. Med Clin (Barc) 2002;1194:605-9.
12. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32:277-87.
13. Maselli JH, Sontang MK, Norris JM, MacKenzie T, Wagener JS, Accurso FJ. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003;35:257-62.
14. Bryan R, Kube D, Pérez A, Davis P, Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cel Mol Biol 1998;19:269-77.
15. Zar H, Saiman L, Quittell L, Prince A. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J Pediatr 1995;126:230-3.
16. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA. Longitudinal relationship among growth, nutritional status and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 2000;137:374-80.
17. Steinkamp G, Wiedemann B, and behalf of the German CFQA Group. Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analysis from the German CF quality assurance (CFQA) project. Thorax 2002;57:596-601.
18. Loubières Y, Grenet D, Simon-Bouy B, Medioni J, Landais P, Férec C, et al. Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients. Chest 2002;121:73-8.
19. Burdet L, Hugli O, Aubert JD, Schutz Y, Roulet M, Fitting JW. Effect of elective antibiotic therapy on resting energy expenditure and inflammation in cystic fibrosis. Eur J Pediatr 1999;158:711-6.
20. Solomon MP, Wilson DC, Corey M, Kalnins D, Zielenski J, Tsui LC, et al. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003;142:128-32.
21. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001;32:343-50.
22. O'Connor GT, Quinton HB, Kneeland T, Kahn R, Lever T, Maddock J, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003;111:e333-9.